Pharmeasy Unlisted Shares
PharmEasy Unlisted Shares- PharmEasy is India’s leading digital healthcare platform, offering a seamless online pharmacy, diagnostics, and teleconsultation experience. As one of the top-funded health tech startups, PharmEasy Unlisted Shares have become a sought-after investment in the pre-IPO market. With its strong market presence, strategic acquisitions, and growing customer base, investing in PharmEasy pre-IPO shares can be a potential game-changer for investors looking for long-term growth.
Market Leadership: PharmEasy dominates India’s online pharmacy space, competing with Tata 1mg, Netmeds, and Apollo 24|7.
Revenue Growth: The company has shown a steady increase in revenue, driven by expanding demand for digital healthcare services.
Backed by Top Investors: PharmEasy is funded by marquee investors like Prosus Ventures, Temasek, and TPG Growth, which reflects its strong market potential.
Expansion Strategy: Strategic acquisitions like Thyrocare and a growing B2B presence in medicine distribution enhance its business model.
If you are looking to buy PharmEasy Unlisted Shares, get in touch with us for PharmEasy Unlisted Share Price, latest updates, and expert insights.
Fundamentals
Current Price | Market Cap | ISIN |
₹8.10 | ₹6430Cr | INE0DJ201029 |
Face Value | P/E Ratio | EPS |
1 | N/A | -3.9 |
P/B Ratio | Book Value | Debt to Equity Ratio |
2.48 | 4.03 | 1.58 |
Board of Directors & Management
Name | Designation | |
Dr. Dhaval Shah | Co-Founder, CBO |  |
Siddharth Shah | CEO | |
